Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
63,912,936
-
Share change
-
-654,754
-
Total reported value
-
$2,113,531,840
-
Put/Call ratio
-
0%
-
Price per share
-
$33.15
-
Number of holders
-
240
-
Value change
-
-$13,340,766
-
Number of buys
-
136
-
Number of sells
-
106
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2017
As of 30 Jun 2017,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,912,936 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Consonance Capital Management LP, JANUS HENDERSON GROUP PLC, Bank of New York Mellon Corp, STATE STREET CORP, Van Berkom & Associates Inc., ABERDEEN ASSET MANAGEMENT PLC/UK, and DIMENSIONAL FUND ADVISORS LP.
This page lists
240
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.